Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malik Parmar

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine|October 18, 2024
Prevalence of Tuberculosis Infection among Various Risk Groups in India: A Systematic Review and Meta-AnalysisArohi Chauhan, Malik Parmar, Girish Dash, et al.
Journal of Epidemiology and Global Health|November 8, 2017
Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: An operational research from Chennai, IndiaHemant Deepak Shewade, Dina Nair, Joel S Klinton, et al.
Plos One|August 25, 2015
Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in IndiaRajesh D Deshmukh, D J Dhande, Kuldeep Singh Sachdeva, et al.
The Indian Journal of Medical Research|May 19, 2023
The prevalence of tuberculosis infection in India: A systematic review and meta-analysisArohi Chauhan, Malik Parmar, Girish Chandra Dash, et al.
The Indian Journal of Tuberculosis|December 14, 2020
Paradigm shift in efforts to end TB by 2025K S Sachdeva, Malik Parmar, Raghuram Rao, et al.
Plos One|August 5, 2011
Source of previous treatment for re-treatment TB cases registered under the National TB control Programme, India, 2010Kuldeep Singh Sachdeva, Srinath Satyanarayana, Puneet Kumar Dewan, et al.
Plos One|November 11, 2011
Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, IndiaSarabjit S Chadha, B N Sharath, Kishore Reddy, et al.
The Indian Journal of Tuberculosis|March 21, 2020
High prevalence of rifampin-resistant tuberculosis in mountainous districts of IndiaKunchok Dorjee, Tsetan D Sadutshang, Ravinder S Rana, et al.
Plos One|March 29, 2020
The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysisNimalan Arinaminpathy, Gabriela B Gomez, Kuldeep S Sachdeva, et al.
The Indian Journal of Tuberculosis|March 21, 2020
Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysisV S Salhotra, K S Sachdeva, Neelima Kshirsagar, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine|October 18, 2024
Prevalence of Tuberculosis Infection among Various Risk Groups in India: A Systematic Review and Meta-AnalysisArohi Chauhan, Malik Parmar, Girish Dash, et al.
Journal of Epidemiology and Global Health|November 8, 2017
Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: An operational research from Chennai, IndiaHemant Deepak Shewade, Dina Nair, Joel S Klinton, et al.
Plos One|August 25, 2015
Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in IndiaRajesh D Deshmukh, D J Dhande, Kuldeep Singh Sachdeva, et al.
The Indian Journal of Medical Research|May 19, 2023
The prevalence of tuberculosis infection in India: A systematic review and meta-analysisArohi Chauhan, Malik Parmar, Girish Chandra Dash, et al.
The Indian Journal of Tuberculosis|December 14, 2020
Paradigm shift in efforts to end TB by 2025K S Sachdeva, Malik Parmar, Raghuram Rao, et al.
Plos One|August 5, 2011
Source of previous treatment for re-treatment TB cases registered under the National TB control Programme, India, 2010Kuldeep Singh Sachdeva, Srinath Satyanarayana, Puneet Kumar Dewan, et al.
Plos One|November 11, 2011
Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, IndiaSarabjit S Chadha, B N Sharath, Kishore Reddy, et al.
The Indian Journal of Tuberculosis|March 21, 2020
High prevalence of rifampin-resistant tuberculosis in mountainous districts of IndiaKunchok Dorjee, Tsetan D Sadutshang, Ravinder S Rana, et al.
Plos One|March 29, 2020
The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysisNimalan Arinaminpathy, Gabriela B Gomez, Kuldeep S Sachdeva, et al.
The Indian Journal of Tuberculosis|March 21, 2020
Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysisV S Salhotra, K S Sachdeva, Neelima Kshirsagar, et al.
Pageof 4